SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Nikola Tesla

PatientNikola Tesla
Date of birth1980-07-10
IdentifiersMRN HR-NI009-SYN; SSN (made up) 000-09-7408
Document date2026-02-24
AuthorBranimir Kovač-Holt, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week OCD treatment review. [S]

History of Present Illness

Mr. Tesla returns six weeks after starting sertraline 50 mg. He has had no side effects since the first week and has missed no doses. He has had five ERP sessions and has practiced touching door handles without washing for ten minutes, and eating lunch without calculating its volume on two days a week. He washes about 30 times a day. Counting his steps is still hard to resist, and repeating laboratory steps in threes still costs him about two hours a day. He saw the dietitian and now eats three meals on most days. He sleeps about five hours. He has had no suicidal thoughts. [S]

ElementDetail
Interval changeWashing down to about 30 times a day; two meals a week without calculating
PsychotherapyFive ERP sessions with homework
RitualsAbout two hours a day of counting and repeating
NutritionDietitian seen; three meals most days
SafetyNo suicidal thoughts
Y-BOCS24, down from 28

Review of Systems

SystemResultFinding
GastrointestinalNegativeNo nausea or diarrhea
IntegumentaryPositiveHands still dry; no open cracks
PsychiatricPositiveCounting and repeating persist; mood a little better; no suicidal thoughts

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-01-13 to 2026-02-24completedS
Sertraline 100 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-02-24 to 2026-04-07completedS
White petrolatum ointment, apply to both hands after each wash and at bedtimeApply a thin layer to both hands after washing and at bedtimeTopical route2026-01-13activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-02-24Body height188cmS
2026-02-24Body weight64.6kgS
2026-02-24Body mass index (BMI) [Ratio]18.3kg/m2S
2026-02-24Systolic blood pressure116mm[Hg]S
2026-02-24Diastolic blood pressure72mm[Hg]S
2026-02-24Heart rate70/minS
2026-02-24Respiratory rate14/minS
2026-02-24Body temperature36.5CelS
2026-02-24Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-24Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-02-24Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]10{score}S

Physical Exam

Vital signs recorded on 2026-02-24; see the Vital Signs section. [S]

SystemFinding
GeneralThin; more relaxed
SkinExamined with his agreement after he sanitized his hands: dry skin over both hands with no fissures
Mental statusPrecise and engaged; mood "slightly lighter"; affect anxious but reactive; good insight; no suicidal ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Obsessive-compulsive disorder, severe (Y-BOCS 28), with good insight: contamination, symmetry, and number obsessions; washing, counting, repeating in threes, and calculating compulsions; synthetic modern diagnosis linked to his own accounts of counting and calculating rituals and aversionsactiveconfirmed F42.2S — Synthetic modern diagnosis. His rituals and aversions are documented in his own words (D); calling them obsessive-compulsive disorder is a retrospective interpretation (R), and no diagnosis was made in his lifetime.
Irritant contact dermatitis of both hands from washing them 40 to 60 times a dayactiveconfirmed L24.9S — Synthetic consequence of washing compulsions.
Underweight (BMI 18.1) with about 4 kg weight loss over six months, from skipped meals and food-calculating ritualsactiveconfirmed R63.6S — Synthetic nutritional consequence echoing his documented habit of calculating the volume of food before eating.
Insufficient sleep, four hours a night, from late work and night-time ritualsactiveconfirmed Z72.820S — Synthetic sleep problem echoing his documented claims about very short sleep.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyY-BOCS severity score (recorded in the note; no LOINC code found)At baseline and about every 4 to 6 weeks during acute treatmentCompleted today24, down 14 percent from 28; dose increased
SurveyPHQ-9 and GAD-7 for secondary depression and anxietyAt baseline and periodically while depressive or anxiety symptoms are presentCompleted todayPHQ-9 6 (item 9 scored 0); GAD-7 10
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9 when given)Every visit during acute treatmentCompleted todayNo suicidal thoughts, intent, plan, or behavior since the last visit; PHQ-9 item 9 scored 0. Safety plan reviewed
Medication safetySertraline adherence and adverse effects (nausea, diarrhea, sleep, activation, sexual effects)Every visit and two weeks after each dose increaseCompleted todayNo side effects since week one; no missed doses; dose increased to 100 mg, with a nurse call in two weeks
Self-managementExposure and response prevention attendance and homeworkEvery visit during acute treatmentCompleted todayFive sessions; door handles without washing for ten minutes; two meals a week without calculating
ExaminationWeight and BMIEvery visit while underweightCompleted today64.6 kg, BMI 18.3, up 0.8 kg
ExaminationHand skinEvery visit while dermatitis is presentCompleted todayDry; no fissures
Self-managementSleep diaryEvery visit during acute treatmentCompleted todayAbout five hours a night
Medication safetyAntipsychotic augmentation monitoring (weight, glucose, lipids, movement)Only if an antipsychotic is addedNot indicatedNo augmentation; responding to sertraline and ERP

Goal progress:

Guideline basis: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)

Follow-up: Review in six weeks. Next scheduled visit 2026-04-07: twelve-week OCD treatment review. [S]